• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, May 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Preliminary: BRCA variations may work alongside COMT variation to reduce breast cancer

Bioengineer by Bioengineer
May 25, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WASHINGTON (May 25, 2017) — Research looking at genomic data from women with a genetic risk for breast cancer, who may never develop cancer, found their cancer-free state may be related to a second genetic variation. Researchers at the George Washington University (GW) found through looking at data of women with BRCA 1/2 genetic mutations, that some women also have the co-occurrence of a rare COMT genetic variant.

The data set looked at women who volunteered for non-cancer related clinical trials, leading researchers to believe they have not developed cancer or have a family history of cancer.

"Not all mutation carriers develop the disease and the underlying reasons for this should be looked at, particularly with the large data sets now available to researchers," said Anelia Horvath, Ph.D., senior author for the study and associate research professor of pharmacology & physiology at the GW School of Medicine and Health Sciences.

The research, published in the New England Journal of Medicine, outlines a strategy for looking at similar genetic mutations.

"We do not claim the variant is preventative of breast cancer in BRCA 1/2 carriers; further research is needed to make those claims," said Horvath. "What we have done is illustrate a strategy for looking at the many data sets available for scientists today to look at different genes, different mutations, and discover patterns for why someone may never develop the disease predisposed by their high-risk mutation."

The next step would be to do a well-designed wet lab study to further look at this variant and determine whether it is functional or works with another variant to stop the incidence of cancer. Horvath and her research team hope to continue applying this model to other genetic conditions.

###

"Co-Occurrence of COMT and BRCA1/2 Variants in a Population" was published in the New England Journal of Medicine and is available at http://www.nejm.org/doi/full/10.1056/NEJMc1701592#t=article.

Media: To interview Dr. Horvath, please contact Lisa Anderson at [email protected] or 202-994-3121.

About the GW School of Medicine and Health Sciences

Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nation's capital and is the 11th oldest in the country. Working together in our nation's capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national and global communities. smhs.gwu.edu

Media Contact

Lisa Anderson
[email protected]
202-994-3121
@GWtweets

http://www.gwu.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Uncovering C. elegans Immunity via Genetic Screens — Biology

Uncovering C. elegans Immunity via Genetic Screens

May 16, 2026
Congenital Heart Disease’s Lasting Impact on Brain Health — Technology and Engineering

Congenital Heart Disease’s Lasting Impact on Brain Health

May 16, 2026

Metabolic Stress Worsens Parkinson’s via Mitochondrial Ferroptosis

May 16, 2026

Four New Hydroxyl Fatty Acids from Bacillus sp.

May 16, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    844 shares
    Share 338 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    730 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Uncovering C. elegans Immunity via Genetic Screens

Congenital Heart Disease’s Lasting Impact on Brain Health

Metabolic Stress Worsens Parkinson’s via Mitochondrial Ferroptosis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.